Kura Oncology, INC. (KURA) — DEF 14A Filings
All DEF 14A filings from Kura Oncology, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Kura Oncology DEF 14A: Executive Compensation Details
— Apr 11, 2025 Risk: low
Kura Oncology, Inc. filed a DEF 14A on April 11, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including equity -
Kura Oncology Announces 2024 Annual Meeting of Stockholders on June 5
— Apr 12, 2024 Risk: low
Kura Oncology, Inc. (KURA) filed a Proxy Statement (DEF 14A) with the SEC on April 12, 2024. Kura Oncology, Inc. will hold its 2024 Annual Meeting of Stockholde
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX